Infusion pumps
Implantable infusion devices, usually installed in the abdominal region, are used for planned administration of drugs at a given speed and at a certain period of time. Pumps can be used for chemotherapy, antibiotic therapy, rehydration, as well as the administration of antiviral drugs and painkillers. The drugs may be administered intravenously, intraarterially, epidurally subcutaneously or intramuscularly.
Content |
Products
- SynchroMed
- Sigma Spectrum
- Ivenix Infusion System
- Alaris
- MedFusion 4000
- CADD
- BodyGuard
- INS
- Sapphire
- Infusomat
- Volumat MC Agilia
- MEDEV
Chronicle
2020: Pentagon buys tens of millions in Baxter infusion pumps
In mid-November 2020, Baxter signed a $40 million contract with the US Department of Defense for the supply of infusion pumps and additional funds. Baxter's contract includes a fixed-price premium of no more than $40 million, but adjusted depending on the economic situation. At the same time, the volumes and terms of supply of infusion pumps are not specified. It is known that 105 companies participated in the competition for the conclusion of the contract. Read more here.
2017: MRI risks for patients with implantable pumps
On January 11, 2017, the Food and Drug Administration (FDA) issued an official warning for patients using implantable infusion pumps. They are advised to carefully undergo magnetic resonance imaging (MRI).
The FDA published a document that talked about possible problems in the operation of infusion pumps after MRI examinations. In particular, the pump motor can be stopped without the possibility of restarting and incorrect dosing of medicines - excessive or insufficient, as well as the unintentional formation of lumps of drugs in the devices.
The FDA urges doctors and patients to carefully check whether MRI scans can be performed safely when using certain pumps. To do this, first of all, you need to pay attention to the marking of the pump: in the instructions or on the device itself, the designation MR-Conditional should be.
 | Importantly, each model of implantable pumps may have unique requirements that must be met for safe MRI examination. Otherwise, it could lead to serious injury or death, the FDA said in a statement. |  |
The Food and Drug Administration is separately asking specialists in the field of radiation diagnostics to carefully assess the risks and the need for MRI scans for patients who use all kinds of medical devices.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |